{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:18:46Z","timestamp":1768623526591,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-022-03265-7","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T10:02:41Z","timestamp":1658311361000},"page":"2497-2502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study"],"prefix":"10.1007","volume":"54","author":[{"given":"Po-Ming","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"issue":"2","key":"3265_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167\u2013178","journal-title":"Neurourol Urodyn"},{"issue":"1 Pt 1","key":"3265_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jfma.2018.03.006","volume":"118","author":"SP Liu","year":"2019","unstructured":"Liu SP et al (2019) The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan. J Formos Med Assoc 118(1 Pt 1):170\u2013178","journal-title":"J Formos Med Assoc"},{"key":"3265_CR3","doi-asserted-by":"crossref","unstructured":"Nambiar AK et al (2022) European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol 82(1):49\u201359","DOI":"10.1016\/j.eururo.2022.01.045"},{"issue":"3","key":"3265_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","volume":"202","author":"DJ Lightner","year":"2019","unstructured":"Lightner DJ et al (2019) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. J Urol 202(3):558\u2013563","journal-title":"J Urol"},{"issue":"5","key":"3265_CR5","first-page":"386","volume":"99","author":"HC Kuo","year":"2000","unstructured":"Kuo HC (2000) Videourodynamic study for diagnosis of bladder outlet obstruction in women. J Formos Med Assoc 99(5):386\u2013392","journal-title":"J Formos Med Assoc"},{"key":"3265_CR6","doi-asserted-by":"crossref","unstructured":"Lee CL et al (2022) Effect of videourodynamic subtypes on treatment outcomes of female dysfunctional voiding. Int Urogynecol J 33(5):1283\u20131291","DOI":"10.1007\/s00192-022-05154-0"},{"issue":"Suppl 1","key":"3265_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1757-5672.2011.00131.x","volume":"4","author":"HC Kuo","year":"2012","unstructured":"Kuo HC (2012) Potential biomarkers utilized to define and manage overactive bladder syndrome. Low Urin Tract Symptoms 4(Suppl 1):32\u201341","journal-title":"Low Urin Tract Symptoms"},{"issue":"1","key":"3265_CR8","doi-asserted-by":"publisher","first-page":"23242","DOI":"10.1038\/s41598-021-02617-0","volume":"11","author":"PM Chow","year":"2021","unstructured":"Chow PM, Hsiao SM, Kuo HC (2021) Identifying occult bladder outlet obstruction in women with detrusor-underactivity-like urodynamic profiles. Sci Rep 11(1):23242","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"3265_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","volume":"339","author":"LL Wu","year":"2004","unstructured":"Wu LL et al (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339(1\u20132):1\u20139","journal-title":"Clin Chim Acta"},{"issue":"12","key":"3265_CR10","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1093\/carcin\/13.12.2241","volume":"13","author":"S Loft","year":"1992","unstructured":"Loft S et al (1992) Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 13(12):2241\u20132247","journal-title":"Carcinogenesis"},{"issue":"8","key":"3265_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/01.CIR.0000026393.47805.21","volume":"106","author":"W Martinet","year":"2002","unstructured":"Martinet W et al (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106(8):927\u2013932","journal-title":"Circulation"},{"key":"3265_CR12","doi-asserted-by":"crossref","unstructured":"Holbrook J et al (2019) Tumour necrosis factor signalling in health and disease. F1000Res 8:F1000 Faculty Rev-111","DOI":"10.12688\/f1000research.17023.1"},{"issue":"4","key":"3265_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000368510","volume":"40","author":"FF He","year":"2015","unstructured":"He FF et al (2015) Tumor necrosis factor-alpha and 8-hydroxy-2\u2032-deoxyguanosine are associated with elevated urinary angiopoietin-2 level in type 2 diabetic patients with albuminuria. Kidney Blood Press Res 40(4):355\u2013365","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"3265_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcb.2015.12.002","volume":"26","author":"H Blaser","year":"2016","unstructured":"Blaser H et al (2016) TNF and ROS crosstalk in inflammation. Trends Cell Biol 26(4):249\u2013261","journal-title":"Trends Cell Biol"},{"key":"3265_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross SH, Cantrell DA (2018) Signaling and function of interleukin-2 in t lymphocytes. Annu Rev Immunol 36:411\u2013433","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3265_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1084\/jem.20061198","volume":"204","author":"AV Villarino","year":"2007","unstructured":"Villarino AV et al (2007) Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med 204(1):65\u201371","journal-title":"J Exp Med"},{"issue":"4\u20135","key":"3265_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1359-6101(02)00022-9","volume":"13","author":"A Schimpl","year":"2002","unstructured":"Schimpl A et al (2002) IL-2 and autoimmune disease. Cytokine Growth Factor Rev 13(4\u20135):369\u2013378","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"3265_CR18","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.juro.2007.06.044","volume":"178","author":"O Yokoyama","year":"2007","unstructured":"Yokoyama O et al (2007) Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure. J Urol 178(5):2208\u20132212","journal-title":"J Urol"},{"issue":"2","key":"3265_CR19","doi-asserted-by":"publisher","first-page":"F585","DOI":"10.1152\/ajprenal.90273.2008","volume":"295","author":"X Su","year":"2008","unstructured":"Su X et al (2008) An excitatory role for peripheral EP3 receptors in bladder afferent function. Am J Physiol Renal Physiol 295(2):F585\u2013F594","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4 Pt 1","key":"3265_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/S0022-5347(05)64522-3","volume":"168","author":"MA Wheeler","year":"2002","unstructured":"Wheeler MA et al (2002) Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer. J Urol 168(4 Pt 1):1568\u20131573","journal-title":"J Urol"},{"issue":"5","key":"3265_CR21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","volume":"175","author":"JC Kim","year":"2006","unstructured":"Kim JC et al (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175(5):1773\u20131776 (discussion 1776)","journal-title":"J Urol"},{"issue":"1","key":"3265_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/iju.12652","volume":"22","author":"M Nomiya","year":"2015","unstructured":"Nomiya M, Andersson KE, Yamaguchi O (2015) Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms. Int J Urol 22(1):40\u201346","journal-title":"Int J Urol"},{"issue":"1","key":"3265_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0022-5347(17)55287-8","volume":"124","author":"WE Kaplan","year":"1980","unstructured":"Kaplan WE, Firlit CF, Schoenberg HW (1980) The female urethral syndrome: external sphincter spasm as etiology. J Urol 124(1):48\u201349","journal-title":"J Urol"},{"issue":"4","key":"3265_CR24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0022-5347(17)45077-4","volume":"136","author":"F Hinman Jr","year":"1986","unstructured":"Hinman F Jr (1986) Nonneurogenic neurogenic bladder (the Hinman syndrome)\u201315 years later. J Urol 136(4):769\u2013777","journal-title":"J Urol"},{"issue":"1","key":"3265_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/UROS.UROS_155_20","volume":"32","author":"M Chancellor","year":"2021","unstructured":"Chancellor M, Lamb L (2021) Toward a validated diagnostic test with machine learning algorithm for interstitial cystitis. Urol Sci 32(1):2\u20137","journal-title":"Urol Sci"},{"issue":"10","key":"3265_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127456","volume":"4","author":"DG Moledina","year":"2019","unstructured":"Moledina DG et al (2019) Urine TNF-alpha and IL-9 for clinical diagnosis of acute interstitial nephritis. JCI Insight 4(10):e127456","journal-title":"JCI Insight"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03265-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-022-03265-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03265-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T13:28:59Z","timestamp":1662730139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-022-03265-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["3265"],"URL":"https:\/\/doi.org\/10.1007\/s11255-022-03265-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"1 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consents were obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of the Buddhist Tzu Chi University (TCGH IRB: 107-37-A).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}